M E15 (Enalapril 2.5 mg)

Pill imprint M E15 has been identified as Enalapril maleate 2.5 mg.

Enalapril is used in the treatment of high blood pressure; heart failure; diabetic kidney disease; hypertensive emergency; alport syndrome (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Enalapril 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Enalapril maleate

Imprint:

M E15

Strength:

2.5 mg

Color:

White

Size:

6.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Angiotensin converting enzyme inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-1051

Inactive Ingredients:

lactose anhydrous
silicon dioxide
magnesium stearate
maleic acid
microcrystalline cellulose
corn starch
sodium lauryl sulfate

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
51079-0950	UDL Laboratories Inc
35356-0541	Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.